Beam Therapeutics Inc.(BEAM)
NASDAQ

Stock Price Forecast & Analyst Targets

$34.14
1.66 (5.11%)

BEAM Stock Forecast Chart

BEAM Stock Forecast 2026 – Price Prediction, Target & Outlook

Beam Therapeutics Inc. (BEAM) stock forecast for 2026 indicates a wide range of potential outcomes based on analyst targets and model-driven predictions. As of June 2026, BEAM stock shows a dynamic price pattern in the short term, with price targets reflecting potential future volatility across bull, base, and bear scenarios over the next 12 months.

BEAM Bull Case Price Target (2027)

$75.64

In a bullish scenario, BEAM stock could reach this maximum projection over the next 12 months, driven by upside momentum and outperforming technical indicators.

BEAM Base Forecast (2027)

$42.96

The base case model predicts this median target, assuming BEAM maintains steady growth, consistent volume profiles, and normalized market conditions.

BEAM Bear Case Price Target (2027)

$10.29

In a broader market downturn or bearish correction, BEAM shares could potentially trace back to this support level over the forecast horizon.

Confidence:44.7% (Low)
Signal:Short-Term Bullish
6M + 12M
Historical
Forecast Avg
Max Range
Min Range
Prophet Model Forecast

Beam Therapeutics Inc. Analyst Consensus & Target Price

Wall Street sentiment and price target analysis for BEAM

STRONG BUY

Consensus based on 15 analysts

High conviction buy - significant upside potential

Mean Target Price
$51.07+49.6%
High Target$80.00
Low Target$26.00
Number of Opinions15

Price Target Analysis

Target Range: $26.00 - $80.00

Current vs Mean Target: +49.6%

Analyst Coverage: 15 firms tracking

Key Considerations

• Target prices reflect 12-month outlook

• Based on fundamental analysis and DCF models

• Consider market volatility in timing decisions

BEAM stock Price Projections & Forecast Models

Data-driven price predictions based on technical analysis and analyst consensus for BEAM

Model-Based Predictions

$34.88
1-Month Target
+2.2%
$42.96
1-Year Target
+25.8%

Analyst Consensus

$51.07
Analyst Mean Target
+49.6% vs Current

Model Methodology & Confidence

Technical Indicators:

  • • Moving averages (SMA 20, 50, 200)
  • • RSI and momentum oscillators
  • • Support/resistance levels
  • • Volume-price analysis

Fundamental Factors:

  • • Earnings growth projections
  • • Revenue trend analysis
  • • Valuation multiple normalization
  • • Sector performance correlation

Scenario Analysis Chart

Beam Therapeutics Inc. (BEAM) Detailed Price Forecast

Algorithmic projections for monthly price bands and momentum signals

According to current predictive modeling and historical volatility analysis, the company is projected to fluctuate between a potential low of $10.29 and a high of $75.64 over the forecast horizon. These estimates blend near-term technical momentum with fundamental analyst consensus targets.

PeriodMin PriceAvg PriceMax PricePotential ROISignal
Jul 202627.2234.8842.53+2.2%
Hold
Aug 202624.5635.6146.67+4.3%
Hold
Sep 202622.5336.3550.17+6.5%
Buy
Oct 202620.8037.0853.36+8.6%
Buy
Nov 202619.2537.8256.38+10.8%
Buy
Dec 202617.8238.5559.28+12.9%
Buy
Jan 202716.4739.2962.10+15.1%
Buy
Feb 202715.1740.0264.87+17.2%
Buy
Mar 202713.9240.7667.60+19.4%
Buy
Apr 202712.6941.4970.30+21.5%
Buy
May 202711.4842.2372.97+23.7%
Buy
Jun 202710.2942.9675.64+25.8%
Buy

Source methodology: Model forecasts are independent estimates blending technical signals with analyst consensus data. Actual market prices are subject to volatility and macroeconomic factors. All projections are for informational purposes only.